Company intelligence / Profile preview

MedPharmics

Metairie, Louisiana, United States

Ownership: Private
Employees: ~24
Development stage: Other

Overview

MedPharmics operates as a multi-site clinical research organization conducting primarily phase II and phase III clinical trials across primary care, women’s health, vaccines, pediatrics and other therapeutic areas; no specific drug development pipeline or trial outcome data is disclosed, as it functions as a service provider rather than a product developer.[2]

Industry: Contract Research Organization

Partnerships

Sponsors and clinical research organizations utilizing MedPharmics/Velocity sites for phase II and III clinical trials (individual pharma sponsors not named)[2]

Beyond the preview

Go deeper on MedPharmics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedPharmics.

Explore the full profile